Doug Shepard
Insider
First SEC filing: Jan. 2, 2008 · Latest: Jan. 2, 2008
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2016 | HHS | F | 165,650 | · | · | 104,118 Direct | -61.40% | Disposed | (price as of 2026-10-02) |
| July 7, 2016 | HHS | F | 7,172 | $1.51 | $10,830 | 269,768 Direct | -2.59% | Disposed | -69.8% (price as of 2026-10-02) |
| April 15, 2016 | HHS | F | 6,561 | $2.69 | $17,649 | 201,940 Direct | -3.15% | Disposed | -83.0% (price as of 2026-10-02) |
| Feb. 5, 2016 | HHS | F | 3,265 | $3.27 | $10,677 | 208,501 Direct | -1.54% | Disposed | -86.1% (price as of 2026-10-02) |
| July 7, 2015 | HHS | A | 78,671 | · | · | 211,766 Direct | +59.11% | Acquired | (price as of 2026-10-02) |
| April 15, 2015 | HHS | A | 83,098 | · | · | 83,098 Direct | · | Acquired | (price as of 2026-10-02) |
| April 15, 2015 | HHS | A | 40,209 | · | · | 133,095 Direct | +43.29% | Acquired | (price as of 2026-10-02) |
| April 15, 2015 | HHS | F | 3,014 | $7.68 | $23,148 | 92,886 Direct | -3.14% | Disposed | -94.1% (price as of 2026-10-02) |
| Feb. 5, 2015 | HHS | F | 4,898 | $7.76 | $38,008 | 95,900 Direct | -4.86% | Disposed | -94.1% (price as of 2026-10-02) |
| April 15, 2014 | HHS | A | 75,000 | · | · | 276,940 Direct | +37.14% | Acquired | (price as of 2026-10-02) |
| April 15, 2014 | HHS | A | 79,893 | · | · | 79,893 Direct | · | Acquired | (price as of 2026-10-02) |
| April 15, 2014 | HHS | A | 34,187 | · | · | 100,798 Direct | +51.32% | Acquired | (price as of 2026-10-02) |
| Feb. 5, 2014 | HHS | F | 6,379 | $7.01 | $44,717 | 66,611 Direct | -8.74% | Disposed | -93.5% (price as of 2026-10-02) |
| Feb. 5, 2013 | HHS | A | 30,000 | · | · | 72,990 Direct | +69.78% | Acquired | (price as of 2026-10-02) |
| Sept. 18, 2012 | HHS | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 5, 2012 | HHS | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 5, 2012 | HHS | A | 15,000 | · | · | 42,990 Direct | +53.59% | Acquired | (price as of 2026-10-02) |
| Feb. 5, 2011 | HHS | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 5, 2011 | HHS | A | 13,600 | · | · | 27,990 Direct | +94.51% | Acquired | (price as of 2026-10-02) |
| Dec. 31, 2010 | HHS | F | 2,298 | $12.72 | $29,231 | 14,390 Direct | -13.77% | Disposed | -96.4% (price as of 2026-10-02) |
| Feb. 5, 2010 | HHS | A | 75,000 | · | · | 75,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 5, 2009 | HHS | A | 90,000 | · | · | 90,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 31, 2008 | HHS | F | 1,147 | $6.24 | $7,157 | 16,688 Direct | -6.43% | Disposed | -92.7% (price as of 2026-10-02) |
| Feb. 14, 2008 | HHS | P | 6,000 | $16.81 | $100,860 | 17,835 Direct | +50.70% | Acquired | -97.3% (price as of 2026-10-02) |
| Feb. 5, 2008 | HHS | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 31, 2007 | HHS | A | 50,000 | · | · | 0 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 31, 2007 | HHS | A | 7,500 | $17.30 | $129,750 | 11,835 Direct | +173.01% | Acquired | -97.4% (price as of 2026-10-02) |
| Dec. 31, 2007 | HHS | A | 4,335 | $17.30 | $74,996 | 4,335 Direct | · | Acquired | -97.4% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 15, 2015 | HHS | Common Stock (right to buy) | Common Stock | $7.68 | April 15, 2025 | 83,098 | Acquired |
| April 15, 2014 | HHS | Stock Option (right to buy) | Common Stock | $8.23 | April 15, 2024 | 79,893 | Acquired |
| Sept. 18, 2012 | HHS | Stock Option (right to buy) | Common Stock | $7.25 | Sept. 18, 2022 | 60,000 | Acquired |
| Feb. 5, 2012 | HHS | Stock Option (right to buy) | Common Stock | $9.91 | Feb. 5, 2022 | 40,000 | Acquired |
| Feb. 5, 2011 | HHS | Stock Option (right to buy) | Common Stock | $12.31 | Feb. 5, 2021 | 10,000 | Acquired |
| Feb. 5, 2010 | HHS | Stock Option (right to buy) | Common Stock | $11.90 | Feb. 5, 2020 | 75,000 | Acquired |
| Feb. 5, 2009 | HHS | Stock Option (right to buy) | Common Stock | $6.04 | Feb. 5, 2019 | 90,000 | Acquired |
| Feb. 5, 2008 | HHS | Common Stock | Common Stock | $15.90 | Feb. 5, 2018 | 15,000 | Acquired |
| Dec. 31, 2007 | HHS | Stock Option (right to buy) | Common Stock | $17.30 | Dec. 31, 2017 | 50,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 2, 2008 | HHS | No Securities owned | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2009 | $315,000 | · | · | $134,433 | $78,750 | $13,077 | $24,269 | $565,529 |
| 2008 | $344,167 | · | · | · | · | $18,149 | $15,770 | $560,894 |
| 2007 | $1,346 | $150,000 | · | · | · | · | · | $151,346 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.